Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers.
View Top Employees from Allogene Therapeutics| Website | https://www.allogene.com |
| Ticker | ALLO |
| Revenue | $25 million |
| Employees | 412 (412 on RocketReach) |
| Founded | 2017 |
| Address | 210 E Grand Ave, South San Francisco, California 94080, US |
| Phone | (650) 457-2700 |
| Technologies |
JavaScript,
HTML,
Twitter
+70 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Keywords | Cancer Treatment |
| Competitors | Alector, CARsgen Therapeutics, Dynavax Technologies, Mirati Therapeutics Inc, Sorrento Therapeutics, Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5413 Companies, NAICS Code 54138 Companies, NAICS Code 541 Companies, NAICS Code 325414 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Allogene Therapeutics employee's phone or email?
Allogene Therapeutics Questions
The Allogene Therapeutics annual revenue was $25 million in 2024.
412 people are employed at Allogene Therapeutics.
Allogene Therapeutics is based in South San Francisco, California.
The NAICS codes for Allogene Therapeutics are [54, 5413, 54138, 541, 325414, 32541, 32, 3254, 325].
The SIC codes for Allogene Therapeutics are [28, 283].
Top Allogene Therapeutics Employees
-
13
-
5+5+
-
25+
-
42
-
ViewStephen Hardt
SVP Supply Chain and External Manufacturing at Allogene Therapeutics
California, United States35 -
ViewShalini Gidwani
Senior Vice President, Global Regulatory Affairs at Allogene Therapeutics
California, United States4 -
35+
-
View
Christine Cassiano
EVP, Chief Corporate Affairs & Brand Strategy Officer at Allogene Therapeutics
Los Angeles, CA, US45+
Related Companies
